479 related articles for article (PubMed ID: 16465622)
1. Bladder cancer predisposition: a multigenic approach to DNA-repair and cell-cycle-control genes.
Wu X; Gu J; Grossman HB; Amos CI; Etzel C; Huang M; Zhang Q; Millikan RE; Lerner S; Dinney CP; Spitz MR
Am J Hum Genet; 2006 Mar; 78(3):464-79. PubMed ID: 16465622
[TBL] [Abstract][Full Text] [Related]
2. High-order interactions among genetic polymorphisms in nucleotide excision repair pathway genes and smoking in modulating bladder cancer risk.
Chen M; Kamat AM; Huang M; Grossman HB; Dinney CP; Lerner SP; Wu X; Gu J
Carcinogenesis; 2007 Oct; 28(10):2160-5. PubMed ID: 17728339
[TBL] [Abstract][Full Text] [Related]
3. High-order interactions among genetic variants in DNA base excision repair pathway genes and smoking in bladder cancer susceptibility.
Huang M; Dinney CP; Lin X; Lin J; Grossman HB; Wu X
Cancer Epidemiol Biomarkers Prev; 2007 Jan; 16(1):84-91. PubMed ID: 17220334
[TBL] [Abstract][Full Text] [Related]
4. Mutagen sensitivity and genetic variants in nucleotide excision repair pathway: genotype-phenotype correlation.
Lin J; Swan GE; Shields PG; Benowitz NL; Gu J; Amos CI; de Andrade M; Spitz MR; Wu X
Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):2065-71. PubMed ID: 17932354
[TBL] [Abstract][Full Text] [Related]
5. Genetic variants in cell cycle control pathway confer susceptibility to bladder cancer.
Ye Y; Yang H; Grossman HB; Dinney C; Wu X; Gu J
Cancer; 2008 Jun; 112(11):2467-74. PubMed ID: 18361427
[TBL] [Abstract][Full Text] [Related]
6. Concordance of multiple analytical approaches demonstrates a complex relationship between DNA repair gene SNPs, smoking and bladder cancer susceptibility.
Andrew AS; Nelson HH; Kelsey KT; Moore JH; Meng AC; Casella DP; Tosteson TD; Schned AR; Karagas MR
Carcinogenesis; 2006 May; 27(5):1030-7. PubMed ID: 16311243
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive pathway-based interrogation of genetic variations in the nucleotide excision DNA repair pathway and risk of bladder cancer.
Xing J; Dinney CP; Shete S; Huang M; Hildebrandt MA; Chen Z; Gu J
Cancer; 2012 Jan; 118(1):205-15. PubMed ID: 21692063
[TBL] [Abstract][Full Text] [Related]
8. Nucleotide excision repair gene polymorphisms and recurrence after treatment for superficial bladder cancer.
Gu J; Zhao H; Dinney CP; Zhu Y; Leibovici D; Bermejo CE; Grossman HB; Wu X
Clin Cancer Res; 2005 Feb; 11(4):1408-15. PubMed ID: 15746040
[TBL] [Abstract][Full Text] [Related]
9. Nucleotide excision repair pathway genes and oral premalignant lesions.
Wang Y; Spitz MR; Lee JJ; Huang M; Lippman SM; Wu X
Clin Cancer Res; 2007 Jun; 13(12):3753-8. PubMed ID: 17575242
[TBL] [Abstract][Full Text] [Related]
10. Polymorphisms in XPD exons 10 and 23 and bladder cancer risk.
Schabath MB; Delclos GL; Grossman HB; Wang Y; Lerner SP; Chamberlain RM; Spitz MR; Wu X
Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):878-84. PubMed ID: 15824159
[TBL] [Abstract][Full Text] [Related]
11. Polymorphisms of the DNA repair genes XRCC1, XRCC3, XPD, interaction with environmental exposures, and bladder cancer risk in a case-control study in northern Italy.
Shen M; Hung RJ; Brennan P; Malaveille C; Donato F; Placidi D; Carta A; Hautefeuille A; Boffetta P; Porru S
Cancer Epidemiol Biomarkers Prev; 2003 Nov; 12(11 Pt 1):1234-40. PubMed ID: 14652287
[TBL] [Abstract][Full Text] [Related]
12. DNA repair gene polymorphisms, bulky DNA adducts in white blood cells and bladder cancer in a case-control study.
Matullo G; Guarrera S; Carturan S; Peluso M; Malaveille C; Davico L; Piazza A; Vineis P
Int J Cancer; 2001 May; 92(4):562-7. PubMed ID: 11304692
[TBL] [Abstract][Full Text] [Related]
13. XPD codon 751 polymorphism, metabolism genes, smoking, and bladder cancer risk.
Stern MC; Johnson LR; Bell DA; Taylor JA
Cancer Epidemiol Biomarkers Prev; 2002 Oct; 11(10 Pt 1):1004-11. PubMed ID: 12376500
[TBL] [Abstract][Full Text] [Related]
14. Genetic variations in base excision repair pathway and risk of bladder cancer: a case-control study in the United States.
Xie H; Gong Y; Dai J; Wu X; Gu J
Mol Carcinog; 2015 Jan; 54(1):50-7. PubMed ID: 24038406
[TBL] [Abstract][Full Text] [Related]
15. Polymorphisms/haplotypes in DNA repair genes and smoking: a bladder cancer case-control study.
Matullo G; Guarrera S; Sacerdote C; Polidoro S; Davico L; Gamberini S; Karagas M; Casetta G; Rolle L; Piazza A; Vineis P
Cancer Epidemiol Biomarkers Prev; 2005 Nov; 14(11 Pt 1):2569-78. PubMed ID: 16284380
[TBL] [Abstract][Full Text] [Related]
16. Genetic variation in the base excision repair pathway and bladder cancer risk.
Figueroa JD; Malats N; Real FX; Silverman D; Kogevinas M; Chanock S; Welch R; Dosemeci M; Tardón A; Serra C; Carrato A; García-Closas R; Castaño-Vinyals G; Rothman N; García-Closas M
Hum Genet; 2007 Apr; 121(2):233-42. PubMed ID: 17203305
[TBL] [Abstract][Full Text] [Related]
17. Study on bladder cancer susceptibility and genetic polymorphisms of XPC, XPG, and CYP in smokers and non-smokers.
Wen H; Feng CC; Fang ZJ; Xia GW; Jiang HW; Xu G; Huang XD; Ding Q
Actas Urol Esp; 2013 May; 37(5):259-65. PubMed ID: 23246108
[TBL] [Abstract][Full Text] [Related]
18. Polymorphisms in DNA repair genes, smoking, and bladder cancer risk: findings from the international consortium of bladder cancer.
Stern MC; Lin J; Figueroa JD; Kelsey KT; Kiltie AE; Yuan JM; Matullo G; Fletcher T; Benhamou S; Taylor JA; Placidi D; Zhang ZF; Steineck G; Rothman N; Kogevinas M; Silverman D; Malats N; Chanock S; Wu X; Karagas MR; Andrew AS; Nelson HH; Bishop DT; Sak SC; Choudhury A; Barrett JH; Elliot F; Corral R; Joshi AD; Gago-Dominguez M; Cortessis VK; Xiang YB; Gao YT; Vineis P; Sacerdote C; Guarrera S; Polidoro S; Allione A; Gurzau E; Koppova K; Kumar R; Rudnai P; Porru S; Carta A; Campagna M; Arici C; Park SS; Garcia-Closas M;
Cancer Res; 2009 Sep; 69(17):6857-64. PubMed ID: 19706757
[TBL] [Abstract][Full Text] [Related]
19. Genetic variation in the nucleotide excision repair pathway and bladder cancer risk.
García-Closas M; Malats N; Real FX; Welch R; Kogevinas M; Chatterjee N; Pfeiffer R; Silverman D; Dosemeci M; Tardón A; Serra C; Carrato A; García-Closas R; Castaño-Vinyals G; Chanock S; Yeager M; Rothman N
Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):536-42. PubMed ID: 16537713
[TBL] [Abstract][Full Text] [Related]
20. Chromosome instability in lymphocytes: a potential indicator of predisposition to oral premalignant lesions.
Wu X; Lippman SM; Lee JJ; Zhu Y; Wei QV; Thomas M; Hong WK; Spitz MR
Cancer Res; 2002 May; 62(10):2813-8. PubMed ID: 12019158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
